Mechanism of action of the immunosuppressant rapamycin
- 1 March 1999
- journal article
- review article
- Published by Elsevier
- Vol. 58 (5) , 373-395
- https://doi.org/10.1016/0024-3205(95)02233-3
Abstract
No abstract availableKeywords
This publication has 157 references indexed in Scilit:
- The Rapamycin and FKBP12 Target (RAFT) Displays Phosphatidylinositol 4-Kinase ActivityPublished by Elsevier ,1995
- Activation of p70/p85 S6 kinase by a pathway independent of p21fi rasNature, 1994
- A Putative Sirolimus (Rapamycin) Effector ProteinBiochemical and Biophysical Research Communications, 1994
- Molecular Cloning and Expression of a Novel Human Gene That Is Highly Homologous to Human FK506-Binding Protein 12kDa (hFJBP-12) and Characterization of Two Alternatively Spliced TranscriptsBiochemical and Biophysical Research Communications, 1994
- Rapamycin: A novel immunosuppressive macrolideMedicinal Research Reviews, 1994
- A Nonimmunosuppressive Triene-Modified Rapamycin Analog Is a Potent Inhibitor of Peptidyl Prolyl cis-trans-IsomeraseBiochemical and Biophysical Research Communications, 1993
- Target of rapamycin in yeast, TOR2, is an essential phosphatidylinositol kinase homolog required for G1 progressionCell, 1993
- In vitro IgE production by interleukin 4-stimulated human peripheral blood mononuclear cells is suppressed by rapamycinClinical Immunology and Immunopathology, 1991
- Interleukin 1 signal transductionImmunology Today, 1990
- A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilinNature, 1989